Carl Plager
Impact in
- Oncology top 1%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Vascular Tumors and Angiosarcomas
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
- Oncology 45
- Cancer Immunotherapy and Biomarkers 10
- Cutaneous Melanoma Detection and Management 9
- Vascular Tumors and Angiosarcomas 7
- Hematology 14
- Multiple Myeloma Research and Treatments 8
- Co-authors
- Robert S. BenjaminOmar EtonAgop Y. BedikianSewa S. LeghaSigrid RingShreyaskumar PatelNicholas E. PapadopoulosAntônio C. Buzaid
- Journals
- Cancer (15 papers)Journal of Clinical Oncology (14 papers)Melanoma Research (9 papers)Anti-Cancer Drugs (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Carl Plager
71 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 99
- Oncology 2.4k
- Immunology 833
- Pulmonary and Respiratory Medicine 1.2k
- Ophthalmology 333
- Rheumatology 283
Countries citing papers authored by Carl Plager
This map shows the geographic impact of Carl Plager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Plager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Plager more than expected).
Fields of papers citing papers by Carl Plager
This network shows the impact of papers produced by Carl Plager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Plager. The network helps show where Carl Plager may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carl Plager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 57 | |
| 2 | 2002 | 87 | |
| 3 | 1998 | 221 | |
| 4 | 1998 | 4 | |
| 5 | 1998 | 167 | |
| 6 | 1997 | 18 | |
| 7 | 1997 | 189 | |
| 8 | 1995 | 12 | |
| 9 | 1994 | 41 | |
| 10 | 1994 | 8 | |
| 11 | 1993 | 5 | |
| 12 | Primary chemotherapy for osteosarcoma with systemic adriamycin and intra-arterial cisplatin | 1990 | 2 |
| 13 | 1990 | 6 | |
| 14 | 1989 | 73 | |
| 15 | 1989 | 136 | |
| 16 | 1989 | 101 | |
| 17 | 1987 | 22 | |
| 18 | Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018. | 1987 | 48 |
| 19 | 1985 | 1 | |
| 20 | 1984 | 17 |
About Carl Plager
Carl Plager is a scholar working on Oncology, Hematology, Pulmonary and Respiratory Medicine, Gastroenterology and Immunology, having authored 71 papers that have together received 3.7k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (19 papers), Melanoma and MAPK Pathways (13 papers), Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cutaneous Melanoma Detection and Management (9 papers), Multiple Myeloma Research and Treatments (8 papers), Vascular Tumors and Angiosarcomas (7 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). The work is most often cited by research in Oncology (2.4k citations), Immunology (833 citations), Pulmonary and Respiratory Medicine (1.2k citations), Ophthalmology (333 citations) and Rheumatology (283 citations). Carl Plager has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Robert S. Benjamin, Omar Eton, Agop Y. Bedikian, Sewa S. Legha, Sigrid Ring, Shreyaskumar Patel, Nicholas E. Papadopoulos, Antônio C. Buzaid, Nikolaos G. Papadopoulos and Nicholas Papadopolous. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Melanoma Research, Anti-Cancer Drugs and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.